Frequency of impaired mephenytoin 4′-hydroxylation in an Indian population [letter]
- 1 November 1990
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 30 (5), 779-780
- https://doi.org/10.1111/j.1365-2125.1990.tb03850.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- Induction of polymorphic 4′‐hydroxylation of S‐mephenytoin by rifampicin.British Journal of Clinical Pharmacology, 1990
- Genetic polymorphism of S-mephenytoin hydroxylationPharmacology & Therapeutics, 1989
- Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland ChineseClinical Pharmacology & Therapeutics, 1989
- Effects of ketoconazole on the polymorphic 4‐hydroxylations of S‐ mephenytoin and debrisoquine.British Journal of Clinical Pharmacology, 1989
- Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data.Proceedings of the National Academy of Sciences, 1988
- Mephenytoin hydroxylation in the Cuna Amerindians of Panama.British Journal of Clinical Pharmacology, 1988
- LOW FREQUENCY OF SLOW DEBRISOQUINE HYDROXYLATION IN A NATIVE CHINESE POPULATIONThe Lancet, 1987
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984